Mark Hogarth

Professor Mark Hogarth is an Adjunct Professor (Research) in Immunology at Monash University, affiliated with Alfred Hospital. His work focuses on immune system roles in autoimmunity, cancer, and inflammation, with translational research into drug development. He holds NHMRC Senior Principal Research Fellow appointments and has led institutions like the Austin Research Institute.

Research Interests: Investigating Fc receptors in immune responses, monoclonal antibodies for disease treatment, and biomarkers for conditions like rheumatoid arthritis and lupus. His lab explores therapeutic applications in cancer (leukemia, breast/colon cancers), infections (HIV, malaria), and immune disorders.

Key Projects: Includes SARS-CoV-2 antibody studies (2022-2025), Fc receptor interactions (2018-2020), and HIT thrombosis mechanisms (2018-2020). Recent work emphasizes vaccine immunity and antibody effector functions.

Awards: Recipient of the Gottschalk Medal (1992) and Sir Albert Coates Oration (2011). His contributions span academic leadership, industry partnerships, and technology transfer via licensing to pharmaceutical companies.

Grants & Teams: Active in NHMRC-funded projects and collaborative drug development. His research integrates basic science with clinical applications, impacting therapies for diverse diseases through immune modulation strategies.